Symbol Lookup

Thursday September 03, 2015 6:47 AM ET. Data delayed 15 minutes.
0.06
0.00 (0.00%)
Bid/Lots
0.00/0
Ask/Lots
0.00/0
Open/Prev Close
0.00/0.06
Day Range
-----
52-Week Range
0.04-0.38
Vol/Avg Daily Vol
0.0/1.2M
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
Guided Therapeutics Expands Access of the LuViva(R) Advanced Cervical Scan into Bulgaria
8:05AM ET on Wednesday Aug 26, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has expanded access to the LuViva(R) Advanced Cervical Scan to Bulgaria, bringing to 21 the number of countries where the Company has shipped its non-invasive,...

Guided Therapeutics Expands Access of the LuViva(R) Advanced Cervical Scan into Costa Rica
8:05AM ET on Tuesday Aug 25, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that access to the LuViva(R) Advanced Cervical Scan has been expanded to Costa Rica, bringing to 20 the number of countries where the Company has shipped its non-invas...

Guided Therapeutics Submits Proposal to Kenya to Increase Cervical Cancer Screening Rates - Potential Screening Population of 12 Million Women
8:05AM ET on Thursday Aug 20, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP), in cooperation with its distributor, Stem World Enterprises, is working with the Kenyan National Ministry of Health (MOH) to help achieve First Lady Margret Kenyatta's Beyond Zero pr...

Guided Therapeutics Advances LuViva PMA Application with FDA
8:05AM ET on Tuesday Aug 18, 2015 by Business Wire

Guided Therapeutics, Inc. (OTCQB: GTHP) today announced that it has presented the U.S. Food and Drug Administration (FDA) with a plan for advancing the pre-market approval (PMA) application for the LuViva(R) Advanced Cervic...

Guided Therapeutics Reports Second Quarter 2015 Financial Results; Closes $10 Million Deal
4:05PM ET on Wednesday Aug 12, 2015 by Business Wire

--$10 million deal with Turkey Ministry of Health for cervical cancer screening

--Chinese partner selected; work on regulatory and business operations underway

--First commercial shipments to Indonesia; pilot screening study to be...

Company Information

Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company's focus is the sales and marketing of its LuViva Advanced Cervical Scan. LuViva is a non-invasive cervical cancer detection product, based on the Company's biophotonic technology. The device is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. The information presented by the light is used to indicate the likelihood of cervical cancer or precancers. LuViva is also designed to detect the biochemical changes that precede the development of visual lesions. It has approval to sell the product LuViva in Canada, Mexico, Singapore, the European Union and additional countries. It has completed the pivotal trial for LuViva and has filed its premarket approval (PMA) application with the United States Food and Drug Administration (FDA).

CONTACT INFORMATION

Headquarters5835 Peachtree Cors E Ste D
NORCROSS, GA, United States 30092-3413
Phone770-242-8723
Fax302-655-5049

EXECUTIVE OFFICERS

Independent Chairman and DirectorMichael James
President, Chief Executive Officer and Acting Chief Financial OfficerGene Cartwright
Senior Vice President - EngineeringRichard Fowler
Independent DirectorRonald Hart
Independent DirectorJohn Imhoff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$6.8MBeta0.69
Revenue (TTM)$724.0KEPS$-0.12
Shares Out.113.7MBook Value$-0.05
Guided Therapeutics Inc does not pay a dividend.P/E--
Price/Sales (TTM)9.4
P/Cash Flow (TTM)--
Operating Margin-1,099.86%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample